Compass Therapeutics CMPX
NASDAQ CMPX
$0.81 -0.02 (-2.26%)
At close: Oct 21, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Preferred Stock Liabilities (2018 - 2020)

Updated

Compass Therapeutics (CMPX) reported Preferred Stock Liabilities of $129.87 million for FY2020.

Analysis

Compass Therapeutics (CMPX) Preferred Stock Liabilities (2018 - 2020) Analysis & Trends

  • According to Business Quant data, Preferred Stock Liabilities came in at $129.87 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Compass Therapeutics 152.17 Mn -653.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 129.87 Mn
Dec 31, 2019 129.87 Mn
Sep 30, 2019 129.87 Mn
Jun 30, 2019 129.87 Mn
Mar 31, 2019 129.87 Mn
Dec 31, 2018 129.87 Mn
API Access

Compass Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CMPX&period=max&api_key=YOUR_API_KEY